跳至主要内容
临床试验/TCTR20230623001
TCTR20230623001已完成4 期

Comparing the Efficacy of a Novel Blue Silver Nanoparticles Hydrogel versus Reference Hydrogel: A Prospective Randomized Controlled Trial for Acute and Chronic Wound Management

ovatec Healthcare Co.,Ltd.0 个研究点目标入组 62 人开始时间: 2023年6月23日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
62

研究概览

简要总结

The blue AgNPs and reference hydrogels were comparable in terms of wound area reduction and pain scores during the changing of wound dressings, with no significant differences. Patients in the blue AgNPs hydrogel group showed low rates of bacterial infection for both gram-negative and gram-positive strains; in particular, there was almost complete prevention of infection by gram-positive strains at day 21 after treatment initiation.

研究设计

研究类型
Interventional

入排标准

年龄范围
10 Years 至 80 Years(—)
性别
All

入选标准

  • 1. All participants were required to be more than 10 years of age and have acute or chronic partial- or full-thickness wounds
  • 2. wounds due to thermal burns and accidental injury were included.

排除标准

  • 1. Patients were pregnant, allergic to hydrogel or silver.
  • 2. Patients had a compromised immune system, or had any other connective tissue disease.
  • 3. Infected wounds with frank pus or necrotic tissues were also excluded.

研究者

发起方
ovatec Healthcare Co.,Ltd.

相似试验